Nikolaos Savvopoulos has graduated from Aristotle University of Thessaloniki with a BSc degree in Biology and specialization in Molecular Biology, Genetics and Biotechnology. During his undergraduate studies, he was working on the development of multi-pathogen specific T cells assessing their efficacy and safety in mouse xenograft models. He was also involved in monitoring of patient’s immune reconstitution post HSCT.
Following his graduation, he pursued a MSc degree in Cell and Gene Therapy at University College London (UCL) and subsequently he worked as a Research Assistant at the UCL Cancer Institute on projects involving the generation of conventional and “off-the-shelf” CAR T cells, employing next-generation gene editing technologies.
Currently, he is enrolled in a PhD program at the Bone Marrow Transplantation Lab, School of Medicine, University of Patras working on evaluation of nanobodies as “safety switches” in T cell immunotherapy and on the development of a GMP-compliant protocol for further clinical application as part of a collaboration (Assistant Professor K.Nika, Department of Biochemistry, School of Medicine, University of Patras & ProtAtOnce, Ltd).